We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Naveen Pereira

Naveen L Pereira MD, FACC

Consultant for the Division of Cardiovascular Diseases and Assistant Professor of Medicine and Pharmacology, Mayo Clinic College of Medicine, Rochester, MN

Naveen L. Pereira, M.D., is a Consultant for the Division of Cardiovascular Diseases and Assistant Professor of Medicine and Pharmacology, Mayo Clinic College of Medicine. He is board certified in internal medicine, cardiovascular diseases and advanced heart failure and transplant.

Dr. Pereira earned his medical degree at University of Bombay. He completed his internship and residency at the University of Connecticut and cardiac fellowship at the Brown University Hospital System and Massachusetts General Hospital. 

Dr. Pereira has received many awards including the Mayo Clinic Department of Medicine Career Development Award, Marie Ingalls Cardiovascular Career Development Award, Academic Research in Cardiology Award, Transplant Center Scholarly Program Award, and Clinical Immunology and Immunotherapeutic Program Award. He was a recipient of the Clinical and Translational Sciences KL2 Award with a focus on functional genomics and translating the genetics of pharmacotherapy. He is a member of the Functional Genomics and Translational Biology Council of the American Heart Association and on the editorial board of Circulation: Cardiovascular Genetics. His laboratory is focused on demonstrating the significance of genetic variation in in-vitro cell systems. He is the overall Principal Investigator of the international multi-center clinical trial, TAILOR PCI that is evaluating the individualization of anti-platelet therapy after percutaneous coronary intervention using genetics at the bedside.

Dr. Pereira’s research interests include treatment of endstage heart failure, antibody-mediated rejection in heart transplant, cardiac allograft hypertrophy, functional genomics and pharmacogenomics.